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In 2007, Dr. Jia-Xiang Shen received the “Outstanding
Contribution Award” at the centenary celebrations of Chi-
nese Pharmaceutical Association. Dr. Shen was acknowl-
edged for his study on the new methodology for the total
synthesis of chloramphenicol, the industrialization of several
important steroid hormone drugs, and for being a co-founder
of Chinese modern pharmaceutical industry.
Dr. Shen was born on November 11, 1921 in Yangzhou,
Jiangsu Province, and later on moved to Nanjing with his
parents. As a teenager, he studied at Nanjing Municipal High
School where he was well trained. When the War of Resis-
tance against Japanese Aggression broke out in 1937, the
school was suspended. To make things worse, Dr. Shen got
infected with tuberculosis, so he had no choice but moving to
Chongqing with his family. One year later, with excellent
exam scores, Dr. Shen was admitted to the National
Advanced Pharmacy College (the predecessor of China
Pharmaceutical University), which was just moved from
Nanjing to Chongqing. During this time, Dr. Shen became
extremely interested in Medicinal Chemistry with the inﬂu-
ence of Prof. Xinghan Lei. This period of educational expe-
riences, though turbulent but self-disciplined, laid foundation
for his life-long path on pharmacy.
After graduation, Dr. Shen worked shortly in the Army
Pharmaceutical Institute. Then, he went to England to study
at the School of Pharmacy in University of London, U.K
(Fig. 1). It took him only four years to complete all the
courses required for both bachelor and doctoral degrees.
Dr. Shen received his PhD degree in Medicinal Chemistry
from University of London in 1949 (Linnell and Shen, 1949;
Linnell and Shen, 1951). Immediately after graduation, he
made up his mind to return back to China. He was so eager
to devote himself to the development of the newly founded
People’s Republic of China that he couldn’t even wait to
receive the award of his PhD certiﬁcate. On September 23,
1949, Dr. Shen boarded on a ship and began the voyage
back to his homeland via Hong Kong. He became one of the
ﬁrst Western-trained Chinese scholars returning back to
China. Since then, Dr. Shen has dedicated his entire life to
the development of pharmaceutical industry in China and is
renowned as one of the founding members of pharmaceu-
tical industry.
During the Korean War, Dr. Shen took the task to lead the
development of chloramphenicol, a badly-needed antibiotic
for wounded Chinese soldiers. Under his guidance, a new
synthetic method of chloramphenicol was developed. Within
a few years, he achieved many signiﬁcant technical inno-
vations during the production processes, which signiﬁcantly
improved the manufacturing technique of chloramphenicol
(Fig. 2). In 1957, the new technique was successfully applied
into large-scale production, which is hailed as an important
milestone marking the beginning of modern pharmaceutical
industry in China (Shen et al., 1950; Shen et al., 1958a, b, c,
d, e, f). In the 1950s and 1960s, he successfully synthesized
crystalline Vitamin A acetate and Vitamin D2 using domestic
resources, supervised the synthesis and production of mul-
tiple steroid medicines such as hydrocortisone and dexam-
ethasone (Shen et al., 1964a, b, c), and accomplished the
total synthesis of gestrinone, which laid a solid foundation for
the industrial synthesis of 19-demethyl steroid drugs in
China.
Towards the end of “Cultural Revolution” in 1973, Dr.
Shen was reappointed as the Deputy Chief Engineer of
Hunan Pharmaceutical Industry Research Institute. Shortly
after that, he embarked on a new research topic based on
effective constituents of Chinese Traditional Medicines
(CTM). He demonstrated the unique chemical structure of
agrimophol through the total synthesis method in 1976
(Shen et al., 1976a, b), which was the active ingredient of an
anti-tapeworm drug. In mid-1980s, he was appointed as the
doctoral advisor in medicinal chemistry at Beijing Medical
University (now part of Peking University) (Fig. 3). He
supervised the PhD candidates on the study of the total
synthesis of Tanshinone IIA and Danshenxinkun B (1986–
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1988) (Shen et al., 1988; Zhang and Shen, 1988), and dis-
covered the special pharmacological activities in some
derivatives. In addition, his group also studied the method-
ology of total synthesis of erycibe alkaloid II (baogongteng A)
and the analogues.
In late 1992, after his retirement, as the Deputy Chief
Engineer of the State Pharmaceutical Administration of
China and the Director General of the National Institutes of
Pharmaceutical R&D, Dr. Shen established Beijing Jicai
Pharmaceutical Research Institute. It was the ﬁrst private
pharmaceutical research institute in China, where he dis-
covered a new crystal form of azithromycin. This discovery
bypassed Pﬁzer’s administrative restriction for azithromycin
dehydrate in China. Later on, this product occupied the
majority of domestic market share of Azithromycin with
competitive price advantages, which substantially improved
the access to the Chinese people. Additionally, his laboratory
also overcame various technical challenges and developed
for the ﬁrst time in China various hard-to-synthesize spe-
cialty generics such as alfacalcidol, tibolone, budesonide,
and tamsulosin.
With the development of China’s science and technology,
Dr. Shen became increasingly recognized in the international
pharmaceutical ﬁeld (Shen and Zhuang, 1984). Given his
distinguished contributions and international reputation in the
ﬁeld of medicinal chemistry, Dr. Shen was elected as the
Communication Academician of France Medication Acad-
emy in 1983. In the 1980s, Dr. Shen attended many con-
ferences held by the United Nations Industrial Development
Organization and the World Health Organization. In 1987, he
was appointed as a member of the World Health Organiza-
tion’s leading group working on the chemotherapy for the
treatment of Malaria and played a critical role in introducing
the anti-malarial medicine artemisinine which was developed
in China to the world (Luo and Shen, 1987; Shen, 1991). In
1988, he held the Directorship of Sino-Searle Foundation. In
1989, he was invited to join the editorial board of Medicinal
Research Reviews and the Journal of Pharmaceutical
Sciences.
Dr. Shen took the development of pharmaceutical sci-
ence, the promotion of China’s pharmaceutical industry and
the health of people as his own duty, and went through an
extraordinary way along the stormy development path of
Chinese pharmaceutical industry. He advanced the basic
research and key technologies of Chinese pharmaceutical
science, advocated the translation and application of
research achievements. With his distinguished achieve-
ments, Dr. Shen won two prizes of National New Product
Award (1964), ﬁve prizes of National Scientiﬁc Conference
Award (1978), the Third Class of National Invention Award
Figure 1. Jia-Xiang Shen at age 24, studying at University
of London (1945).
Figure 2. Jia-Xiang Shen was searching documents for
chloramphenicol at a library (1957).
Figure 3. Dr. Shen was advising his graduate students
at Beijing Medical University (now part of Peking
University) (1987).
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(1982), and the Second Class for Beijing Science and
Technology Progress Award (1999). In 1999, he was elected
as a member of the prestigious Chinese Academy of
Engineering.
Dr. Shen witnessed and experienced China’s poverty
during his youth, and he felt deeply humiliated by the
aggressions of foreign powers. This inspired him to work
hard for China’s rejuvenation and empower the nation with
modern science. He summarized his research style as
“subject driven by mission” and “starting with easy things, but
never leave without digging in great depth”. He always chose
the research topics that are valuable to the development and
progress of the country. He told his students many times, “As
explorers of science, we must uphold the rule of self-re-
liance. Contributing to your country, rather than living on its
support.”
In 2001, at the age of 80, Dr. Shen gave up his quiet and
comfortable life in Beijing and accepted the invitation to join
Tianjin University with the hope of advancing pharmaceutical
science and industry through education. He moved to Tianjin
and co-founded the School of Pharmaceutical Science and
Technology together with other colleagues at Tianjin
University. During the school’s early days, he always worked
in the frontline regardless of his age and health. Everyone at
Tianjin University was deeply inspired by his persevering
spirit, which has become invaluable wealth to this institution.
FOOTNOTES
Materials of this paper was gathered from “Academic Growth Data
Acquisition Project on Outstanding Scientists”, which is supported by
China Association for Science and Technology. The authors want to
thank Jian Shen and Ann Shen, son and daughter of Dr. Jia-Xiang
Shen, for substantial polishing advices during paper preparation.
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